Dale Muzzey, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 2,100 shares at $26.17 ($55K) on 2024-09-11, disclosed to the SEC on 2024-09-12.
Open-market sale of $55k MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.